Drugs like semaglutide, the active ingredient of Ozempic and Wegovy, are more effective in treating type 2 diabetes than ...
A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both ...
A McGill University study of more than 450,000 patients found that incretin-based Type 2 diabetes drugs, including GLP-1 ...
A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both ...
The research has generated significant interest from firms in food & supplements as consumers seek natural alternatives to ...
Background: Lupus nephritis (LN), a severe complication of systemic lupus erythematosus (SLE), is characterized by podocyte injury that contributes to disease progression. Dipeptidyl peptidase-4 ...
Objective: DPP-4 inhibitors are now established agents for glycaemic control in diabetes. Herein, this study systematically characterized cofrogliptin and elucidated its pharmacology, pharmacokinetics ...
GLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend to the curb. A study published in JAMA in January 2025 — which looked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results